EGETIS THERAPEUTICS AB
Current Employees Featured
Official Site Inspections
http://www.egetis.com Semrush global rank: 2.5 M Semrush visits lastest month: 7.04 K
- Host name: 141.193.213.20
- IP address: 141.193.213.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Egetis Therapeutics AB"
Organisation - Egetis Therapeutics
A skilled and experienced organization Egetis’ organization is small, but it is experienced and effective, has a knowledge-intensive network and has unique, integrated drug development …See details»
Corporate presentation - egetis.com
Organization in the EU and North America Strong team with late-stage orphan clinical development, registration and commercialization experience from: ... ‒Egetis drew down …See details»
Egetis Therapeutics
Dec 18, 2024 Calendar and upcoming reports. December 18, 2024. Investor Day (Stockholm & online) February 26, 2025. Year-end Report Q4 2024 (7:00am CET) April 30, 2025See details»
Egetis Therapeutics AB - Crunchbase Company Profile & Funding
Egetis Therapeutics AB may be growing as the company has surpassed earnings expectations in the first quarter of 2024, which is a strong indicator of financial performance. Outperforming …See details»
Egetis - Company Profile - Tracxn
Oct 29, 2024 Egetis - Developer of therapeutics for rare and other diseases. Raised funding from 5 investors. Founded by Nicklas Westerholm in the year 2020. Egetis has 150 …See details»
Egetis Therapeutics AB, Financial Info, Board and Management ...
Egetis Therapeutics AB Return To Hit List Organization Number: 5567066724 . Company; Insights; CONTACT INFORMATION Phone: 08 ...See details»
Egetis Therapeutics AB Company Description - Stock Analysis
6 days ago Egetis Therapeutics AB (publ) was incorporated in 2006 and is based in Stockholm, Sweden. Egetis Therapeutics AB (publ) Country: Sweden: Founded: 2006: Industry: …See details»
Egetis Therapeutics AB Company Description - Stock Analysis
Oct 16, 2024 The company was formerly known as PledPharma AB (publ) and changed its name to Egetis Therapeutics AB (publ) in December 2020. Egetis Therapeutics AB (publ) was …See details»
Egetis Therapeutics - Overview, News & Similar companies
Egetis Therapeutics contact info: Phone number: +46 86797210 Website: www.egetis.com What does Egetis Therapeutics do? Egetis is an innovative, unique and integrated pharmaceutical …See details»
Corporate presentation - Egetis Therapeutics
Orphan drug segment –a highly attractive opportunity Source: (1) Orphan drug development: an economically viable strategy for biopharma R&D, Meekings, Williams & Arrowsmith, 2012; (2) …See details»
Egetis Therapeutics - PitchBook
Egetis Therapeutics General Information Description. Egetis Therapeutics AB is an integrated pharmaceutical drug development company, focusing on projects in late-stage development …See details»
Egetis Therapeutics AB (publ) - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Egetis Therapeutics AB (publ) of Stockholm, Stockholm. Get the latest business insights from Dun & …See details»
Egetis Therapeutics AB Number of Employees - Stock Analysis
Dec 30, 2023 Egetis Therapeutics AB had 28 employees as of December 30, 2023. The number of employees increased by 11 or 64.71% compared to the previous year. Employees 28. …See details»
Governance Egetis Therapeutics AB - MarketScreener.com
Dec 19, 2024 Egetis Therapeutics AB (publ), formerly PledPharma AB (publ) is a Sweden-based pharmaceutical drug development company, focusing on projects in late-stage development …See details»
Egetis initiates the build-up of an organization in the US and …
Egetis has initiated the build-up of medical affairs and the commercial organization During the period we announced four key -up medical affairs and the commercial organization to deliver …See details»
Corporate presentation - egetis.com
Corporate presentation | Egetis Therapeutics | 2021-11-12 11 with clear scientific and mechanistic rationale and established safety profile •Tiratricol is a thyroid hormone analogue with high …See details»
Egetis establishes subsidiary in the United States - Nasdaq
Aug 10, 2022 In the US, after discussions with the FDA, Egetis will conduct a small randomized, placebo-controlled study in 16 patients to verify the results on T3 levels seen in previous …See details»
Egetis continues the build-up of an organization in the US and …
Egetis Therapeutics interim report January-September 2022 1 Interim report January-September 2022 Egetis continues the build-up of an organization in the US and Europe for the …See details»
Corporate presentation - Egetis Therapeutics
Organization in the EU and US Combined core expertise in late-stage orphan clinical development, registration and commercialization with ... Egetis Therapeutics | 2021-04-26 9 …See details»
Egetis Therapeutics AB Market Cap - Stock Analysis
3 days ago Egetis Therapeutics AB has a market cap or net worth of 178.50 million as of January 3, 2025. Its market cap has increased by 29.29% in one year. Market Cap 178.50M. …See details»